Laurent Fischer's most recent trade in Adverum Biotechnologies Inc was a trade of 117,614 Common Stock done at an average price of $4.3 . Disclosure was reported to the exchange on Dec. 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Purchase of securities on an exchange or from another person at price $ 4.31 per share. | 05 Dec 2025 | 117,614 | 201,513 (0%) | 0% | 4.3 | 506,916 | Common Stock |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Purchase of securities on an exchange or from another person at price $ 4.24 per share. | 05 Dec 2025 | 11,085 | 83,899 (0%) | 0% | 4.2 | 47,000 | Common Stock |
| ATAI Life Sciences N.V. | Laurent Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 103,000 | 103,000 | - | - | Stock Option | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2025 | 120,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 110,420 | 110,420 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2025 | 110,420 | 0 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 68,000 | 68,000 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2025 | 68,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 67,502 | 67,502 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2025 | 67,502 | 0 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2025 | 63,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 63,000 | 63,000 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 58,497 | 58,497 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2025 | 58,497 | 0 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 45,499 | 45,499 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2025 | 45,499 | 0 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 31,500 | 31,500 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2025 | 31,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Mirum Pharma Inc | Laurent Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 6,268 | 6,268 | - | - | Stock Option (right to buy) | |
| Mirum Pharma Inc | Laurent Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 3,977 | 3,977 | - | - | Restricted Stock Units | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Sale of securities on an exchange or to another person at price $ 2.00 per share. | 15 May 2025 | 9,126 | 87,488 (0%) | 0% | 2 | 18,252 | Common Stock |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 25,000 | 96,614 (0%) | 0% | 0 | Common Stock | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| ATAI Life Sciences N.V. | Laurent Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 206,000 | 206,000 | - | - | Stock Option | |
| Mirum Pharma Inc | Laurent Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 8,779 | 8,779 | - | - | Stock Option (right to buy) | |
| Mirum Pharma Inc | Laurent Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 5,703 | 5,703 | - | - | Deferred Stock Units | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2023 | 315,000 | 315,000 | - | - | Stock Option (Right to Buy) | |
| Mirum Pharma Inc | Laurent Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 17,000 | 17,000 | - | - | Stock Option (right to buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, President and Director | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 15 Mar 2023 | 41,239 | 692,141 (1%) | 0% | 0.8 | 32,232 | Common Stock |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 930,000 | 930,000 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, President and Director | Sale of securities on an exchange or to another person at price $ 1.07 per share. | 19 Sep 2022 | 41,082 | 727,380 (1%) | 0% | 1.1 | 43,941 | Common Stock |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 675,022 | 675,022 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 584,978 | 584,978 | - | - | Performance Based Stock Option (Right to Buy) | |
| Mirum Pharma Inc | Laurent Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 17,000 | 17,000 | - | - | Stock Option (right to buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, President and Director | Purchase of securities on an exchange or from another person at price $ 1.11 per share. | 20 Apr 2022 | 25,000 | 762,462 (1%) | 0% | 1.1 | 27,800 | Common Stock |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 630,000 | 630,000 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 680,000 | 706,292 (1%) | 1% | 0 | Common Stock | |
| Adverum biotech Inc | Laurent Fischer | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 455,000 | 455,000 | - | - | Stock Option (Right to Buy) | |
| Mirum Pharma Inc | Laurent Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 17,000 | 17,000 | - | - | Stock Option (right to buy) |